Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

Who May Qualify: - 18\<age\<75years - clinic blood pressure≥140/90mmHg or 24-hour ambulatory blood pressure monitoring average blood pressure ≥135/85mmHg - Ecg diagnosis of atrial fibrillation ; - who signed willing to sign a consent form and were approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University. Who Should NOT Join This Trial: - pregnant women or lactating patients; - Patients who were unsuitable for ablation before surgery （unilateral or bilateral renal artery shape and structure were found： renal artery stenosis exceeding 50%, renal aneurysm, previous renal artery interventional surgery, renal artery malformation, renal artery diameter \< 4mm or length of treatable segment \< 20mm） - Patients who only have one kidney or have a history of kidney transplantation - Patients with a history of renal arterial intervention or renal denervation - identified secondary hypertension or Pseudo hypertension except for renal parenchymal hypertension; - malignant tumors or end-stage diseases; - Severe peripheral vascular disease, abdominal aortic aneurysm - whose left atrium is larger than 55mm - obvious bleeding tendency and blood system diseases; - Severe peripheral vascular disease, abdominal aortic aneurysm; - A history of the acute coronary syndrome within two weeks; - acute or severe systemic infection; - drug or alcohol dependence or refusal to sign willing to sign a consent form. - Other conditions that are not suitable for PVI and RDN Always talk to your doctor about whether this trial is right for you.